glp-1 cancer prevention Could GLP-1 Drugs Reduce Obesity-Related Cancers in the Future?

Could GLP-1 medications help slow cancer progression?⁣ ⁣ A new Cleveland Clinic study found those taking GLP-1s were less likely to develop stage IV disease in several cancer types, when compared to

28.90

★★★★☆4.8 (126)

For years, researchers have known that obesity is associated with an increased risk of developing and dying from several cancers, including breast cancer. At ASCO 2026, new studies examining GLP-1 receptor agonists

21.73

★★★★★4.9 (98)

Could GLP-1 medications like Ozempic and Wegovy one day help slow cancer progression?, New research presented at ASCO 2026 suggests these medications may reduce metastatic progression in certain

23.43

★★★★★5.0 (157)

The effect of GLP-1R agonists on the medical triad of obesity, diabetes, and cancer | Cancer and Metastasis Reviews

20.05

★★★★★4.7 (84)

There's a surprising new benefit from taking GLP-1 weight loss drugs—using the medication is associated with lower breast cancer incidents, according to a published study. Latest Medical Watch Daily Digest: ( https://wgntv.com/news/medical-watch/glp-1

21.73

★★★★★4.9 (203)

Glucagon-like peptide-1 medicines and cancer

29.51

★★★★★5.0 (176)

GLP-1 drugs may be linked to a lower risk of cancer progression, according to new research that will be presented next week at the American Society of Clinical Oncology's annual meeting. The

28.34

★★★★★4.8 (132)